Cassava Sciences
SAVA
#9468
Rank
NZ$0.20 B
Marketcap
NZ$4.21
Share price
12.26%
Change (1 day)
31.59%
Change (1 year)

Earnings for Cassava Sciences (SAVA)

Earnings in 2025 (TTM): -NZ$0.2 Billion

According to Cassava Sciences 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -NZ$0.26 Billion a decrease over its 2023 earnings that were of -NZ$0.19 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cassava Sciences from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$0.2 Billion-23.67%
2024 -NZ$0.26 Billion34.28%
2023 -NZ$0.19 Billion32.41%
2022 -NZ$0.15 Billion143.46%
2021 -NZ$58.14 Million383.92%
2020 -NZ$12.02 Million36.96%
2019 -NZ$8.78 Million-25.56%
2018 -NZ$11.79 Million-44.25%
2017 -NZ$21.14 Million-20.11%
2016 -NZ$26.46 Million5.32%
2015 -NZ$25.13 Million14.23%
2014 -NZ$22 Million-139.64%
2013 NZ$55.47 M
2010 -NZ$24.24 Million102.87%
2009 -NZ$11.95 Million-177.52%
2008 NZ$15.41 M-14.32%
2007 NZ$17.98 M-1942.21%
2006 -NZ$0.98 Million
2004 -NZ$68.92 Million75.1%
2003 -NZ$39.36 Million
2001 -NZ$30.63 Million20.49%
2000 -NZ$25.42 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-NZ$0.26 Billion 27.50%๐Ÿ‡บ๐Ÿ‡ธ USA